Clinical Trial

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a retrospective and prospective study aimed to develop and validate the performance of multi-omics assays for early detection of female breast cancer. The study will enroll approximately 496 participants including participants with breast cancers and participants with breast benign diseases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-19.
Trial Details
NCT Number NCT06979921
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Collaborators: Guangzhou Burning Rock Bioengineering Ltd.
Conditions Cancer
Enrollment 496 participants
Start Date 2021-07-10
Primary Completion 2023-05-31 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-14